X
01 Gowling Lafleur Henderson LLP (2)
02 Gowling WLG (Canada) LLP (1)
01 2145985 (1)
02 2286330 (1)
03 2787952 (1)
01 Bevacizumab (3)
01 Concentrate for Solution for Infusion (3)
01 2012-10-28 (1)
02 2018-03-04 (1)
03 2031-02-22 (1)